公司代码：603130 公司简称：云中马 浙江云中马股份有限公司 2024 年年度报告 浙江云中马股份有限公司2024 年年度报告 1 / 272 浙江云中马股份有限公司2024 年年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 天健会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人叶福忠、主管会计工作负责人刘雪梅及会计机构负责人（会计主管人员）刘雪梅 声明：保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 经公司于2025年4月21日召开的第三届董事会第十六次会议审议通过的2024年度利润分配预 案如下： 公司拟以实施权益分派股权登记日登记的总股本为基数，向全体股东每10股派发现金红利 1.00元（含税）。 截至2024年12月31日，公司总股本为137,514,200股，据此测算，预计分派现金红利不超过 13,751,420.00元（含税）。除 ...

Financial Performance - The company achieved total operating revenue of CNY 1,151,652,269.49, representing a year-on-year growth of 32.64%[22]. - Net profit attributable to shareholders reached CNY 245,598,458.46, an increase of 27.26% compared to the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 231,338,948.07, up 31.72% year-on-year[22]. - Cash flow from operating activities amounted to CNY 300,892,601.89, reflecting a significant growth of 54.59%[22]. - The company's total assets increased to CNY 2,013,504,803.94, a year-on-year growth of 14.78%[23]. - Shareholders' equity rose to CNY 1,679,237,143.49, marking an 11.37% increase from the previous year[23]. - Basic earnings per share were CNY 0.76, up 26.67% compared to CNY 0.60 in 2023[21]. - The company's operating costs increased to CNY 764,114,719.26, up 30.82% compared to the previous year[83]. - Research and development expenses rose to CNY 44,462,205.68, marking a 36.56% increase year-on-year[83]. Dividend and Share Capital - The company plans to distribute a cash dividend of RMB 1.40 per 10 shares, totaling RMB 45.23 million for the year, which represents 24.99% of the net profit attributable to shareholders[5]. - The total share capital after the proposed capital reserve transfer will increase from 323,086,400 shares to 420,012,320 shares[5]. - The average cash dividend payout ratio over the last three years is 76.97%, with a total cash dividend of RMB 151.21 million during that period[152]. Product Development and Innovation - The company has successfully launched two major projects: a soluble dietary fiber project with an annual production capacity of 30,000 tons and a crystallized sugar project with a capacity of 15,000 tons, significantly improving production capacity and profitability[31]. - The company has successfully developed and mass-produced isomaltulose and crystallized fructose, enhancing its product structure and competitive edge in the market[36]. - The company has obtained 6 authorized invention patents in 2024 and received various certifications, enhancing its innovation capabilities and market competitiveness[40]. - The company aims to develop 5-6 new product specifications annually and has launched products like sugar-free resistant dextrin and high DE resistant dextrin in 2023[77]. Market Trends and Projections - In 2023, global prebiotic production reached 279,200 tons, generating sales of $1.278 billion, with a projected compound annual growth rate (CAGR) of 6.75% from 2023 to 2030[46]. - By 2030, global prebiotic production is expected to reach 441,200 tons, with sales projected to hit $2.279 billion, reflecting a CAGR of 8.62%[46]. - The global dietary fiber market sales reached $5.14 billion in 2023, with a compound annual growth rate (CAGR) of 6.58% from 2019 to 2023[54]. - The demand for high-fiber staple foods is growing at an annual rate of over 10% in developed countries, driven by health concerns related to chronic diseases[53]. Corporate Governance - The governance structure includes a board of nine directors, with three independent directors, ensuring compliance with legal and regulatory requirements[116]. - The company has maintained independence from its controlling shareholders in terms of personnel, business, assets, and finance, ensuring no interference in operational decisions[119]. - The company plans to continue enhancing its internal control systems in compliance with relevant laws and regulations to promote healthy development[118]. - The company has established specialized committees under the board, including audit, nomination, remuneration, and strategic committees[135]. Environmental Responsibility - The company has been recognized as a national "Green Factory" and a "Waste-Free Factory" in Shandong Province[166]. - The company has implemented a carbon reduction measure, achieving a reduction of 2,290 tons of CO2 equivalent emissions[166]. - The company has established an environmental self-monitoring plan to oversee pollutant emissions and ensure compliance[163]. - The company invested 16.31 million yuan in environmental protection during the reporting period[157]. Strategic Initiatives - The company is focused on improving its corporate governance and operational independence to safeguard shareholder interests[119]. - The management plans to implement a brand development strategy, with a focus on strengthening independent innovation and enhancing the brand's position in the global value chain[110]. - The company is actively pursuing market expansion strategies, targeting new geographic regions to drive growth[124]. - The company is exploring potential mergers and acquisitions to strengthen its market position, with a budget of 500 million RMB allocated for this purpose[126]. Risk Management - The company faces risks from market competition and potential product substitution, emphasizing the need for ongoing R&D investment to maintain technological advantages[113]. - Fluctuations in raw material prices, particularly for starch and sugar, could significantly impact product costs and profit margins[113]. - The company is exposed to exchange rate risks due to its reliance on USD for export settlements, which may affect financial performance[114]. - International trade tensions, particularly between the US and China, pose risks to the company's competitiveness in overseas markets[114].

申能股份有限公司2024 年年度报告 公司代码：600642 公司简称：申能股份 申能股份有限公司 2024 年年度报告 1 / 264 申能股份有限公司2024 年年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、大华会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人华士超、主管会计工作负责人杨波及会计机构负责人（会计主管人员）潘步恩 声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司拟以实施权益分派股权登记日登记的总股本为基数扣除实施权益分派股权登记日公司回 购专用账户中的股份数量后，每 10 股派发现金红利 4.50 元（含税），剩余未分配利润结转至以 后年度。截至 2024 年 12 月 31 日，公司总股本 4,894,094,676 股，公司回购专用账户中的股份数 量为 0，以此计算合计拟分配现金红利 2,202,342,604.2 ...

Financial Performance - The company achieved a net profit attributable to shareholders of 20.86 million yuan in 2024, a significant recovery from a loss of 67.87 million yuan in 2023[5]. - Operating revenue for 2024 was 503.61 million yuan, representing a 24.63% increase compared to 404.08 million yuan in 2023[23]. - The net profit for the year was ¥1,517.34 million, with a net profit attributable to shareholders of ¥2,086.04 million[42]. - The company reported a basic earnings per share of ¥0.0338 for 2024, compared to a loss per share of ¥0.1088 in 2023[155]. - The total comprehensive income for 2024 was CNY 20,790,973.71, a stark contrast to the comprehensive loss of CNY -59,248,629.48 in 2023[159]. - The company reported a significant increase in contract liabilities, rising to 10.24 million yuan from 3.03 million yuan, an increase of approximately 237%[147]. Asset and Liability Management - The total assets decreased by 6.11% to 372.16 million yuan at the end of 2024, down from 396.39 million yuan at the end of 2023[24]. - The company's total liabilities were reported at 323.93 million yuan, down from 410.19 million yuan, representing a reduction of approximately 21%[147]. - The equity attributable to shareholders improved to 42.84 million yuan from a negative 3.14 million yuan, showing a significant recovery[147]. - The company's short-term borrowings decreased to 0, down from 30 million yuan, indicating reduced bank loan obligations[55]. Cash Flow Analysis - The company reported a negative cash flow from operating activities of 39.64 million yuan in 2024, compared to a positive cash flow of 0.28 million yuan in 2023[23]. - The operating cash flow showed a significant improvement, moving from negative CNY 18.47 million in Q1 to positive CNY 3.36 million in Q4[27]. - The cash flow from financing activities generated a net inflow of CNY 16,166,692.86 in 2024, down from CNY 66,056,797.73 in 2023[162]. Business Expansion and Strategy - The company expanded its business by acquiring a 40% stake in Peiran Cosmetics (Jiangsu) Co., enhancing its marketing and operational capabilities in the cosmetics sector[33]. - The company aims to optimize its profit structure and improve gross margins through enhanced brand promotion and live streaming operations for its own cosmetic products[33]. - The company plans to focus on expanding its market presence and enhancing product development in the upcoming year[171]. - The company is exploring potential mergers and acquisitions that align with shareholder interests and support its growth strategy[195]. Governance and Compliance - The company received an audit report with no opinion from the accounting firm, indicating potential concerns regarding financial reporting[5]. - The company has faced regulatory scrutiny, including warnings from the Shanghai Stock Exchange for issues related to information disclosure and internal controls[83]. - The company is committed to improving compliance and has implemented measures to prevent future regulatory issues[84]. - The company has established specialized committees, including an audit committee and a strategic committee, to enhance governance[89]. Shareholder Information - The controlling shareholder has changed from Zhongyu Jiatai to Lishui Lingnan Song, with Lishui Lingnan Song holding 69.8 million shares, representing 11.31% of the total share capital[118]. - The total number of ordinary shareholders as of the end of the reporting period is 15,180[123]. - The company has not reported any changes in shareholding for its directors and senior management during the reporting period[75]. Operational Challenges - The company acknowledges the need for increased operating capital to support its business development plans during its transition period[66]. - The company faces uncertainties as most of its enterprise clients are still recovering, necessitating more operational funding to stabilize and expand its market[67]. - The company has not reported any major acquisitions or market expansion strategies during the reporting period[106]. Employee and Management Structure - The company reported a total of 208 employees, with 127 in sales, 11 in technical roles, 13 in finance, and 57 in administration[92]. - The management team includes experienced professionals with backgrounds in various industries, enhancing strategic decision-making capabilities[76]. - The company has not engaged in any significant related party transactions during the reporting period[75]. Future Outlook - The company aims to achieve profitability in 2025 by optimizing management, reducing costs, and increasing business profitability[64]. - The company is focused on enhancing its internal controls and compliance measures to avoid future regulatory challenges[84]. - The company plans to enhance internal management and governance levels to improve operational efficiency[196].

2024 年第一季度报告 证券代码：688189 证券简称：南新制药 湖南南新制药股份有限公司 2024 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息 的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期比上年同期 增减变动幅度(%) | | --- | --- | --- | | 营业收入 | 136,374,970.14 | -55.03 | | 归属于上市公司股东的净利润 | 18,386,651.64 | 46.71 | | 归属于上市公司股东的扣除非经常性 损益的净利润 | 17,912,994.72 | 10.86 | | 经营活动 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥372,606,893.05, representing a 2.45% increase compared to ¥363,688,244.25 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥5,642,431.49, an improvement of 9.38% from a loss of ¥6,226,320.21 in the previous year[5] - Total operating revenue for the current period reached CNY 372,606,893.05, an increase from CNY 363,688,244.25 in the previous period, reflecting a growth of approximately 0.25%[18] - The net loss for the current period was CNY 5,652,285.11, compared to a net loss of CNY 6,236,459.03 in the previous period, showing an improvement of approximately 9.3%[19] - The company reported a total comprehensive loss of CNY 5,652,285.11 for the current period, compared to a loss of CNY 6,236,459.03 in the previous period, indicating a reduction in losses[20] Cash Flow - The net cash flow from operating activities improved significantly, with a net outflow of ¥23,960,057.57, a 72.30% reduction from ¥86,512,320.82 in the same period last year[5] - Total cash inflow from operating activities was 445,497,111.12 CNY, compared to 358,600,045.61 CNY in the previous period, reflecting a growth of approximately 24.2%[22] - Cash outflow from operating activities totaled 469,457,168.69 CNY, up from 445,112,366.43 CNY, representing an increase of about 5.5%[22] - Cash flow from investing activities was -1,945,004.62 CNY, an improvement from -3,406,412.40 CNY in the previous period[22] - Cash inflow from financing activities was 12,000,000.00 CNY, an increase from 8,000,000.00 CNY, marking a growth of 50%[22] - The net cash flow from financing activities was 10,072,188.49 CNY, compared to 1,391,326.89 CNY in the previous period, showing significant improvement[22] Assets and Liabilities - Total assets decreased by 6.61% to ¥860,029,296.23 from ¥920,860,066.68 at the end of the previous year[5] - Current assets totaled CNY 670,605,629.54, down from CNY 727,735,322.95, representing a decrease of approximately 7.8%[14] - The total liabilities decreased to CNY 765,204,650.00 from CNY 820,383,135.34, reflecting a reduction of about 6.7%[16] - The company's cash and cash equivalents decreased to CNY 39,151,918.33 from CNY 55,184,731.89, a decline of approximately 29.1%[14] - The company's accounts receivable stood at CNY 508,765,484.10, down from CNY 552,739,901.12, indicating a decrease of about 8.0%[14] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 26,702[10] - The largest shareholder, Xiaochang Yingxi Valley Investment Center, holds 22.61% of the shares, with 57,000,000 shares pledged[10] Operating Costs - Total operating costs amounted to CNY 377,666,407.49, up from CNY 369,521,009.64, indicating an increase of about 2.1%[18] - Payments for goods and services amounted to 375,633,494.51 CNY, compared to 341,029,907.49 CNY in the previous period, reflecting an increase of about 10.1%[21] Return on Assets - The weighted average return on net assets was -5.79%, a decline of 1.10 percentage points compared to -4.69% in the previous year[5]

万科企业股份有限公司 2025 年第一季度报告 公告编号：〈万〉2025-054 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或者重 大遗漏。 重要内容提示: 万科企业股份有限公司（以下简称"公司"或"万科"）董事会、监事会及董事、监事、 高级管理人员保证 2025 年第一季度报告（以下简称"本报告"）内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 证券代码：000002、299903 证券简称：万科 A、万科 H 代 公司第二十届董事会第十六次会议审议并通过了本报告。黄力平董事因公务原因未能亲 自出席本次会议，授权辛杰董事代为出席会议并行使表决权；林明彦独立董事因公务原因未 能亲自出席本次会议，授权廖子彬独立董事代为出席会议并行使表决权。除此之外，其他董 事均亲自出席了本次董事会会议。 董事会主席辛杰，执行副总裁、财务负责人韩慧华声明：保证本报告中财务信息的真实、 准确、完整。 本集团（指万科企业股份有限公司及其附属公司）按照中国企业会计准则编制了本报告， 本报告之财务报表未经审计。 除特别指明外，本报告所用记账本位币均为人民币 ...

Financial Performance - The company's operating revenue for Q1 2025 was ¥389,310,959.40, a decrease of 16.03% compared to ¥463,651,026.27 in the same period last year[6]. - The net loss attributable to shareholders for Q1 2025 was ¥112,633,452.25, compared to a net loss of ¥127,530,194.50 in the previous year, indicating an improvement[6]. - The basic and diluted earnings per share for Q1 2025 were both -¥0.07, unchanged from -¥0.08 in the previous year[6]. - Total revenue for Q1 2025 was CNY 389.31 million, a decrease of 16.0% compared to CNY 463.65 million in Q1 2024[20]. - Net loss for Q1 2025 was CNY 114.30 million, compared to a net loss of CNY 127.99 million in Q1 2024, showing an improvement of 10.7%[22]. - Operating profit for Q1 2025 was CNY -111.97 million, slightly better than the operating profit of CNY -118.32 million in Q1 2024[21]. - Research and development expenses for Q1 2025 were CNY 6.31 million, down from CNY 14.32 million in Q1 2024, indicating a reduction of 55.9%[21]. - The company recorded other comprehensive income of CNY 2.39 million in Q1 2025, compared to a loss of CNY 102.90 million in Q1 2024[22]. Cash Flow - The net cash flow from operating activities was ¥17,733,433.17, a significant recovery from a negative cash flow of ¥69,415,071.31 in the same period last year[6]. - In Q1 2025, the net cash flow from operating activities was $17,733,433.17, a significant improvement compared to a net loss of $69,415,071.31 in Q1 2024[25]. - Total cash inflow from operating activities in Q1 2025 was $488,521,261.58, slightly down from $503,145,027.43 in Q1 2024, representing a decrease of approximately 2.5%[25]. - Cash outflow from operating activities decreased to $470,787,828.41 in Q1 2025 from $572,560,098.74 in Q1 2024, indicating a reduction of about 17.8%[25]. - The net cash flow from investing activities was -$2,100,694.99 in Q1 2025, an improvement from -$6,641,532.48 in Q1 2024[26]. - Cash inflow from financing activities in Q1 2025 was $32,596,073.00, compared to $112,959,532.28 in Q1 2024, reflecting a decrease of approximately 71.1%[26]. - The net cash flow from financing activities was $27,357,873.30 in Q1 2025, down from $56,542,033.85 in Q1 2024, indicating a decline of about 51.7%[26]. - The ending cash and cash equivalents balance for Q1 2025 was $88,279,719.42, up from $84,001,879.29 in Q1 2024, showing an increase of approximately 5.4%[26]. - Cash received from other operating activities increased to $97,390,951.94 in Q1 2025 from $77,350,344.50 in Q1 2024, representing a growth of about 25.9%[25]. - The total cash outflow from investing activities in Q1 2025 was $2,100,694.99, a decrease from $13,116,801.18 in Q1 2024, indicating a reduction of approximately 84%[26]. - The impact of exchange rate changes on cash and cash equivalents was -$11,358.53 in Q1 2025, compared to a positive impact of $4,952.18 in Q1 2024[26]. Assets and Liabilities - The total assets at the end of Q1 2025 were ¥7,382,248,448.60, reflecting a slight increase of 0.56% from ¥7,341,052,002.55 at the end of the previous year[6]. - Current assets totaled CNY 2,318,564,774.83, up from CNY 2,210,690,588.27 in the previous period, reflecting a growth of approximately 4.9%[15]. - Accounts receivable increased to CNY 1,058,618,444.84 from CNY 968,547,970.46, representing a rise of about 9.3%[15]. - Cash and cash equivalents rose to CNY 126,699,046.45 from CNY 79,892,094.44, indicating a significant increase of approximately 58.5%[15]. - Total liabilities reached CNY 6,377,127,230.21, compared to CNY 6,204,312,136.45, marking an increase of about 2.8%[16]. - The total non-current liabilities amounted to CNY 1.21 billion, a decrease from CNY 1.22 billion in the previous period[20]. - The total non-current assets decreased to CNY 5,063,683,673.77 from CNY 5,130,361,414.28, reflecting a decline of approximately 1.3%[16]. - The total equity attributable to shareholders of the parent company was CNY -95.14 million, a decline from CNY 15.10 million in the previous period[20]. - The equity attributable to shareholders was -¥95,144,107.98, a significant decrease of 730.20% from ¥15,097,468.70 at the end of the previous year[6]. Audit and Governance - The company faced challenges in ensuring the accuracy and completeness of the financial report due to the previous year's audit report being non-standard and unable to express an opinion[2][4]. - Several board members, including the general manager and financial executives, expressed concerns regarding the reliability of the Q1 2025 financial data based on the previous year's audit findings[4][5]. Shareholder Information - The company reported a total of 64,429 common shares outstanding at the end of the reporting period[11]. - The top shareholder, Shenzhen Xinpengyun Technology Co., Ltd., holds 10.28% of the shares, with 170,329,667 shares frozen[11]. - The company has not reported any significant changes in the top 10 shareholders or their participation in margin trading[12]. - The company has a total of 1,047,232,286.74 in long-term equity investments, slightly down from 1,047,499,445.43[15].

Audit and Financial Reporting - The company received an audit report from Zhongrui Cheng Accounting Firm stating that it could not express an opinion on the financial statements due to significant uncertainties regarding the company's ability to continue as a going concern[6]. - The audit committee's findings were limited due to the historical accounting errors and unresolved regulatory issues, impacting the overall financial reporting[4][6]. - Independent director He Yun abstained from voting on the 2023 annual report due to concerns about the authenticity and completeness of the report, citing significant internal control deficiencies and undisclosed major external investments[132]. - The company received an audit report with a disclaimer of opinion for the 2024 annual financial report, leading to a risk warning for delisting from the Shanghai Stock Exchange[181]. - The company is addressing past accounting errors identified by the China Securities Regulatory Commission, which affected financial statements from 2012 to 2023[174]. Financial Performance - The company's operating revenue for 2023 was approximately ¥1.88 billion, a decrease of 27.99% compared to ¥3.70 billion in 2022[25]. - The net profit attributable to shareholders of the listed company for 2023 was approximately -¥884.66 million, compared to -¥454.06 million in 2022[25]. - The net cash flow from operating activities for 2023 was -¥117.05 million, a decline of 279.31% from ¥65.28 million in 2022[25]. - The total revenue for the first quarter of 2024 is approximately 500.37 million yuan, while the net profit attributable to shareholders is -127.53 million yuan[28]. - The company reported a total net profit of -486.29 million yuan for the fourth quarter of 2024, highlighting ongoing financial challenges[28]. Corporate Governance - The board of directors has established four specialized committees: nomination, investment strategy, audit, and remuneration and assessment, to enhance operational efficiency[103]. - The company has implemented strict measures to maintain independence from its controlling shareholders in terms of assets, personnel, finance, and operations, ensuring no conflicts of interest[105]. - The company has strengthened its information disclosure processes, ensuring timely and accurate communication with all stakeholders[103]. - The company is committed to continuous improvement in corporate governance and compliance with the latest regulatory standards[101]. - The company has engaged a witnessing lawyer for shareholder meetings to ensure the legality and validity of the voting process[102]. Strategic Focus and Future Plans - The company plans to focus on cloud services and digital transformation to enhance its market position[16]. - The company is investing in new technologies, including AI and big data, to improve service offerings[16]. - The company aims to expand its market presence through strategic partnerships and acquisitions[16]. - The company is exploring new product development in the telecommunications sector to drive future growth[16]. - The company plans to focus on core business development to enhance competitiveness and increase revenue[171]. Risks and Challenges - The company has identified potential risks related to its future plans and development strategies, advising investors to be cautious[9]. - The company is currently undergoing a restructuring process, which may affect its financial stability and reporting accuracy moving forward[4]. - The company faces investment risks due to market volatility affecting its external investment projects, necessitating improved management systems for subsidiary collaboration[98]. - The company has faced significant operational risks and financial risks due to ongoing litigation and regulatory scrutiny[166]. - The company reported a significant liquidity issue, with current liabilities exceeding current assets by RMB 3.994 billion as of December 31, 2024[165]. Management and Leadership Changes - The company has undergone significant changes in its board and management structure in 2024[121]. - The company has appointed new executives, including a new general manager and several vice general managers, indicating a restructuring of the management team[126]. - The company has experienced significant turnover in its management team, with multiple resignations and new appointments occurring during the reporting period[126]. - The leadership changes are part of a broader strategy to position the company for future growth and success[114]. - The company has appointed Cheng Lin and Meng Fei as vice presidents, and Wu Wentao as the board secretary on January 16, 2024[117]. Compliance and Regulatory Issues - The company received an administrative penalty notice from the China Securities Regulatory Commission on March 28, 2024, for failing to disclose related party transactions and significant contracts, as well as false records in annual reports from 2012 to 2022[127]. - The company is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations[166]. - The company has committed to timely rectification of identified internal control deficiencies as part of its compliance measures[190]. - The company has established internal control systems to prevent fund occupation by controlling shareholders and related parties, safeguarding the rights of shareholders and stakeholders[192]. - The company has not allocated any funds for environmental protection during the reporting period, with no measures taken to reduce carbon emissions[155]. Shareholder Engagement - The company held a total of 4 shareholder meetings during the reporting period, ensuring compliance with legal and regulatory requirements for convening and conducting these meetings[107]. - The company has adopted a hybrid voting method for shareholder meetings, allowing both on-site and online participation to ensure equal rights for all shareholders[102]. - The company has not identified any instances of insider trading related to sensitive information during the reporting period[103]. - The company has not disclosed any significant changes in related party transactions that were previously disclosed[196]. - The company emphasizes compliance with relevant laws and regulations to prevent future occurrences of fund occupation by controlling shareholders[192].

北京东方通科技股份有限公司 2025 年第一季度报告 证券代码：300379 证券简称：东方通 公告编号：2025-定-003 北京东方通科技股份有限公司 2025 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第一季度报告是否经过审计 □是 否 1 北京东方通科技股份有限公司 2025 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 134,294,019.34 | 75,697,977.39 | 77.41% | | 归属于上市 ...